Unravelling TPX2-centered co-expression networks as key drivers of aggressive prostate cancer
Raheleh Sheibani-Tezerji, Carlos Uziel Perez Malla, Gabriel Wasinger, Katarina Misura, Astrid Haase, Anna Malzer, Jessica Kalla, Loan Tran, Gerda Egger · 2025
Read Unravelling TPX2-centered co-expression networks as key drivers of aggressive prostate cancer by Raheleh Sheibani-Tezerji, Carlos Uziel Perez Malla, Gabriel Wasinger, Katarina Misura, Astrid Haase, Anna Malzer, Jessica Kalla, Loan Tran, Gerda Egger (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-12708838.txt.
Description
Raheleh Sheibani-Tezerji and co-authors search gene activity data for the programs that drive prostate cancer from mild to aggressive forms, in a 2025 study. Telling slow cancers from dangerous ones remains a central problem in care. The team pooled 1,232 samples, spanning healthy prostate tissue and every major stage up to treatment-resistant metastatic disease.
Across all stages, cell division control, DNA repair, and shape-changing programs stayed switched awry. One gene, TPX2, sat at the center of a web of 21 genes that rise together in every stage. Machine learning ranked partner genes for each stage, naming different lead pairs for early, hormone-sensitive, and resistant disease. Stage markers included two known growth drivers in hormone-sensitive disease and a telomere-keeping gene in resistant disease. The authors offer the network as a map for future tests and drug targets.
Catalog record
| CREATOR | Raheleh Sheibani-Tezerji, Carlos Uziel Perez Malla, Gabriel Wasinger, Katarina Misura, Astrid Haase, Anna Malzer, Jessica Kalla, Loan Tran, Gerda Egger |
|---|---|
| YEAR | 2025 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 66 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |